Nucleic acid therapeutics: state of the art and future prospects.
Gewirtz
A M
AM
Departments of Internal Medicine, Pathology and Laboratory Medicine, and the Institute for Human Gene Therapy, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Sokol
D L
DL
Ratajczak
M Z
MZ
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D001692:Biological Transport; D002986:Clinical Trials as Topic; D005544:Forecasting; D005786:Gene Expression Regulation / Q000187:drug effects*; D018390:Gene Targeting; D015316:Genetic Therapy; D019337:Hematologic Neoplasms / Q000235:genetics / Q000628:therapy; D006801:Humans; D008958:Models, Molecular; D016376:Oligonucleotides, Antisense / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D009857:Oncogenes; D016337:RNA, Catalytic / Q000378:metabolism; D013873:Thionucleotides / Q000494:pharmacology; D013917:Thrombin / Q000037:antagonists & inhibitors; D019851:Thrombophilia / Q000628:therapy; D014157:Transcription Factors / Q000037:antagonists & inhibitors / Q000235:genetics; D014158:Transcription, Genetic / Q000187:drug effects
D000925:Anticoagulants; D016376:Oligonucleotides, Antisense; D016337:RNA, Catalytic; D013873:Thionucleotides; D014157:Transcription Factors; D013917:Thrombin